DK675389A - Terapeutiske praeparater til forebyggelse af fibrinaflejringer - Google Patents

Terapeutiske praeparater til forebyggelse af fibrinaflejringer Download PDF

Info

Publication number
DK675389A
DK675389A DK675389A DK675389A DK675389A DK 675389 A DK675389 A DK 675389A DK 675389 A DK675389 A DK 675389A DK 675389 A DK675389 A DK 675389A DK 675389 A DK675389 A DK 675389A
Authority
DK
Denmark
Prior art keywords
fibrine
fleets
prevention
therapeutic preparations
preparations
Prior art date
Application number
DK675389A
Other languages
English (en)
Other versions
DK675389D0 (da
DK175597B1 (da
Inventor
Marjorie A Mohler
Tue H Nguyen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK675389D0 publication Critical patent/DK675389D0/da
Publication of DK675389A publication Critical patent/DK675389A/da
Application granted granted Critical
Publication of DK175597B1 publication Critical patent/DK175597B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK198906753A 1987-07-01 1989-12-29 Anvendelse af en vævsplasminogenaktivator (t-PA) til fremstilling af et præparat til anvendelse til forebyggelse af fibrinaflejring eller adhærencedannelse eller -gendannelse, topiske præparater og dispenseringsindretninger til. DK175597B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US6887287A 1987-07-01 1987-07-01
US6887287 1987-07-01
US12531987A 1987-11-25 1987-11-25
US12531987 1987-11-25
US21089588A 1988-06-24 1988-06-24
US21089588 1988-06-24
US8802194 1988-06-30
PCT/US1988/002194 WO1989000049A1 (en) 1987-07-01 1988-06-30 Method and therapeutic compositions for the prevention of fibrin deposition or adhesions

Publications (3)

Publication Number Publication Date
DK675389D0 DK675389D0 (da) 1989-12-29
DK675389A true DK675389A (da) 1990-02-28
DK175597B1 DK175597B1 (da) 2004-12-13

Family

ID=27371438

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198906753A DK175597B1 (da) 1987-07-01 1989-12-29 Anvendelse af en vævsplasminogenaktivator (t-PA) til fremstilling af et præparat til anvendelse til forebyggelse af fibrinaflejring eller adhærencedannelse eller -gendannelse, topiske præparater og dispenseringsindretninger til.

Country Status (14)

Country Link
EP (1) EP0297860B1 (da)
JP (1) JP2756131B2 (da)
KR (1) KR0131330B1 (da)
AU (1) AU621305B2 (da)
DE (1) DE3883645T2 (da)
DK (1) DK175597B1 (da)
FI (1) FI103868B (da)
IE (1) IE65658B1 (da)
IL (2) IL86933A (da)
NO (1) NO301748B1 (da)
NZ (1) NZ225260A (da)
PH (1) PH26527A (da)
PT (1) PT87886B (da)
WO (1) WO1989000049A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741149A1 (de) * 1987-12-04 1989-06-15 Thomae Gmbh Dr K Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen
US5364622A (en) * 1987-12-04 1994-11-15 Dr. Karl Thomae Gmbh Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
AU7073994A (en) * 1993-07-02 1995-01-24 Quest International B.V. Packaging of enzymes
US5869810A (en) * 1995-05-23 1999-02-09 Victor Reynolds Impedance-heated furnace
DE19529223A1 (de) * 1995-08-09 1997-02-13 Boehringer Mannheim Gmbh Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
JP2001522813A (ja) * 1997-11-07 2001-11-20 カイロン コーポレイション 新規のｉｇｆ−ｉ組成物およびその使用
US7067485B2 (en) 1997-11-07 2006-06-27 Chiron Corporation IGF-I composition and its use
FR2918276B1 (fr) * 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
DE102014112212A1 (de) 2014-08-26 2016-03-03 Akesion Gmbh Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung
JPS6218742A (ja) * 1985-07-18 1987-01-27 Sony Corp ヒ−トシンクの製造方法
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
AU586306B2 (en) * 1985-12-16 1989-07-06 Ethicon Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator

Also Published As

Publication number Publication date
JPH04502753A (ja) 1992-05-21
IE65658B1 (en) 1995-11-15
FI896359A0 (fi) 1989-12-29
DE3883645D1 (de) 1993-10-07
KR890701124A (ko) 1989-12-19
NO895338L (no) 1990-02-28
IL86933A (en) 1993-07-08
WO1989000049A1 (en) 1989-01-12
IE882023L (en) 1989-01-01
NO301748B1 (no) 1997-12-08
DE3883645T2 (de) 1994-02-03
NO895338D0 (no) 1989-12-29
JP2756131B2 (ja) 1998-05-25
NZ225260A (en) 1991-03-26
AU621305B2 (en) 1992-03-12
AU1998588A (en) 1989-01-30
FI103868B1 (fi) 1999-10-15
DK675389D0 (da) 1989-12-29
PT87886A (pt) 1989-06-30
DK175597B1 (da) 2004-12-13
EP0297860A1 (en) 1989-01-04
EP0297860B1 (en) 1993-09-01
IL102625A0 (en) 1993-01-14
FI103868B (fi) 1999-10-15
KR0131330B1 (ko) 1998-04-17
PH26527A (en) 1992-08-07
PT87886B (pt) 1993-09-30

Similar Documents

Publication Publication Date Title
DK437188A (da) Fremgangsmaade til kryopreservering af hjerteklapper
DE3873127D1 (de) Therapeutische praeparate.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
DK397388A (da) Derivater af n-aminobutyl-n-phenylarylamider til terapeutisk anvendelse samt fremgangsmaade til fremstilling af saadanne derivater
DK675389D0 (da) Terapeutiske praeparater til forebyggelse af fibrinaflejringer
DK226488A (da) Anvendelse af ace-inhibitorer til fremstilling af farmaceutiske praeparater
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO865028D0 (no) Fremgangsmaate for fremstilling av et terapeutisk system.
DK271588D0 (da) Genteknologisk fremgangsmaade til fremstilling af angiogeniner
DK537687A (da) Fremgangsmaade til fremstilling af n-substituerede piperazinoner
DK240989A (da) 2-halogen-4,5-difluorbenzoesyre-forbindelser og fremgangsmaader til fremstilling deraf samt fremgangsmaade til fremstilling af 1-cyclopropyl-6,7-difluor-1,4-dihydro-4-oxo-quinolin-3-carboxylsyreestere
DK28788D0 (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK0458855T3 (da) Farmaceutisk præparat til behandling af tonsillitis
DK601489A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK500589D0 (da) Farmaceutisk praeparat til behandling af lungeobstruktioner
DK106589A (da) Fremgangsmaade til fremstilling af aenaturligtae methylanthranilat
DK97388A (da) Mellemprodukt og fremgangsmaade til fremstilling af antihypercholestrolemiske tetrazolforbindelser
DK4488D0 (da) Fremgangsmaade til fremstilling af krystallinsk aminobeskyttet beta-benzyl-l-asparaginsyre
DK142788D0 (da) Fremgangsmaade til fremstilling af chlorerede olefiner
NO864689D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive peptider.
DK68790A (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler
DK162789D0 (da) Fremgangsmaade til fremstilling af alkalimetalphenylpyruvat
DK646188A (da) Fremgangsmaade til fremstilling af halogenalkyllactamer
DK492686D0 (da) Vacumtelt til terapeutisk behandling
DK688287D0 (da) Poroes saarforbinding samt fremgangsmaade til fremstilling af denne

Legal Events

Date Code Title Description
PUP Patent expired